Raymond C. Stevens
Chief Executive Officer at Structure Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Danaher Corporation, 3 years.
Danaher Corporation
Director
Structure Therapeutics Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
Structure Therapeutics Inc.
· Chief Executive Officer
Since February 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 15, 2026 | Danaher Corporation | Grant or award | +680 | — | — |
| Mar 19, 2026 | Structure Therapeutics Inc. | Grant or award | +260,217 | — | — |
| Mar 3, 2026 | Structure Therapeutics Inc. | Shares withheld for tax | −53,454 | $20.99 | $1,121,999 |
| Jul 1, 2025 | Structure Therapeutics Inc. | Grant or award | +89,697 | — | — |
| Jul 1, 2025 | Structure Therapeutics Inc. | Shares withheld for tax | −16,050 | $6.84 | $109,782 |
| May 15, 2025 | Danaher Corporation | Grant or award | +577 | — | — |
| Mar 15, 2025 | Structure Therapeutics Inc. | Grant or award | +340,332 | — | — |
| Mar 1, 2025 | Structure Therapeutics Inc. | Shares withheld for tax | −12,495 | $7.92 | $98,960 |
| Jun 12, 2024 | Structure Therapeutics Inc. | Option exercise | +99,999 | $0.39 | $39,000 |
| Jun 12, 2024 | Structure Therapeutics Inc. | Option exercise | +50,001 | $0.48 | $24,000 |
| Jun 10, 2024 | Structure Therapeutics Inc. | Derivative conversion | −555,000 | — | — |
| May 15, 2024 | Danaher Corporation | Grant or award | +390 | — | — |
| Mar 15, 2024 | Structure Therapeutics Inc. | Grant or award | +134,682 | — | — |
| May 15, 2023 | Danaher Corporation | Grant or award | +430 | — | — |
| Jan 25, 2023 | Danaher Corporation | Option exercise | +3,540 | $83.28 | $294,811 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.